Therapeutics R&D
AB Biosciences (ABB) is dedicated to R&D of niche protein therapeutics for treatment of immune-oncological indications.
The knowledge base in immunoregulation and the technological expertise in protein engineering form the ABB’s core competence in targeting on immune molecules and pushing for versatile therapeutic applications.
Research Projects
-
-
PD-L1 Decoy
Learn MoreCancer treatment via symbiosis with tumor tissues through slowing down the progression of cancer-triggered cachexia.
-
Abmining
Learn MoreMassive antibody mining, an unique platform for accelerating R&D timelines of therapeutic antibodies.
-
